Orifarm says goodbye to generics CEO following new focus on generic medicine
Orifarm has presented a new strategy, which is focused on Orifarm producing its own generic medicine, therefore the company has said goodbye to the CEO of the company's generics business. "We have simply removed a layer of management," says Deputy CEO.
The Danish company Orifarm has said goodbye to Ulrik Rasmussen, who was CEO of the company's generic business.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
